Sue Naeyaert, senior director of Biosimilars Policy, EMD Serono, discusses the long-term impact that biosimilars could potentially have on the field of oncology.
Sue Naeyaert,
Articles by Sue Naeyaert,
Latest Updated Articles
Impact of Biosimilars on OncologyMay 20th 2016